•How should we think about risk for populations using in vitro screening of (human) cells?
•Many caveats are obvious, but bear repeating: Many caveats are obvious, but bear repeating:
-limitations of the in vitro environment -cell type -sources of technical variation sources of technical variation
•On the other hand, we are working with the correct species and there is m ch that can be done species, and there is much that can be done:
-heritability analysis -identification of potential mechanisms underlying variability, tl i ti i mostly via genetic mapping -characterization of average response and variation across agents/chemicals, to prioritize -in vitro data used for predictive toxicity models 3 •The screening can be cost-effective, though not exactly cheap exactly cheap
•Economies of scale and savings arise from use of well-studied cell lines
•Why not do screening using just a few cell lines? y g gj What do we gain from trying to understand population variation?
-in risk assessment, we need to understand variation at the population level Screening lots of different lines unmasks sources of -Screening lots of different lines unmasks sources of heterogeneity that would otherwise be hidden The concept of population toxicity involves means and true variability
Measurement variation
The concept of population toxicity involves means and true variability, obscured by technical variation
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Measure of susceptibility/resistance 19 The concept of population toxicity involves means and true variability The concept of population toxicity involves means and true variability, obscured by technical variation A vulnerable subpopulation subpopulation 20 The concept of population toxicity involves means and true variability The concept of population toxicity involves means and true variability, obscured by technical variation • Toxicity screening data will be (is!) matched by extremely deep 'omics y y p profiling of lymphoblast cell lines • The availability of sequencing data will enable the exploration of rare SNP variants • One of the first large datasets to be fully profiled by sequence-based RNA profiling profiling • The extensive characterization of these samples will enable dissection of genetic variability 
